Global Markets Directs, Can-Fite BioPharma Ltd. Product Pipeline Review 2015, provides an overview of the Can-Fite BioPharma Ltd.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Can-Fite BioPharma Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope The report provides brief overview of Can-Fite BioPharma Ltd. including business description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of Can-Fite BioPharma Ltd.s human therapeutic division and enlists all their major and minor projects The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones Special feature on out-licensed and partnered product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Can-Fite BioPharma Ltd.s pipeline products Reasons to buy Evaluate Can-Fite BioPharma Ltd.s strategic position with total access to detailed information on its product pipeline Assess the growth potential of Can-Fite BioPharma Ltd. in its therapy areas of focus

1.
Most up­to­date research on "Can­Fite BioPharma Ltd. ­ Product Pipeline Review ­ 2015" to its huge
collection of research reports.
Global Markets Directs, Can­Fite BioPharma Ltd. Product Pipeline Review 2015, provides an overview of
the Can­Fite BioPharma Ltd.s pharmaceutical research and development focus.
Request To Download Sample Report @ http://www.researchmoz.us/enquiry.php?
type=sample&repid=285962
This report provides comprehensive information on the current therapeutic developmental pipeline of
Can­Fite BioPharma Ltd.s, complete with comparative analysis at various stages, therapeutics assessment
by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also
reviews latest updates, and featured news and press releases, along with special features on late­stage and
discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is built using data and information sourced from Global
Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations
and featured press releases from company/university sites and industry­specific third party sources, put
together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic

2. updation following a stringent set of processes that ensures that all the profiles are updated with the latest
set of information. Additionally, processes including live news & deals tracking, browser based alert­box
and clinical trials registries tracking ensure that the most recent developments are captured on a real time
basis.
Browse Detail Report With TOC @ http://www.researchmoz.us/can­fite­biopharma­ltd­product­
pipeline­review­2015­report.html
The report enhances decision making capabilities and help to create effective counter strategies to gain
competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce
first­in­class and best­in­class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of
data for the indicated disease.
Scope
The report provides brief overview of Can­Fite BioPharma Ltd. including business description, key
information and facts, and its locations and subsidiaries
The report reviews current pipeline of Can­Fite BioPharma Ltd.s human therapeutic division and enlists
all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products
along with the products developmental history and major milestones
Special feature on out­licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects

3. Latest company statement
Latest news and deals relating to the Can­Fite BioPharma Ltd.s pipeline products
For Market Research Latest Reports Visit @ http://www.researchmoz.us/latest­report.html
Reasons to buy
Evaluate Can­Fite BioPharma Ltd.s strategic position with total access to detailed information on its
product pipeline
Assess the growth potential of Can­Fite BioPharma Ltd. in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Can­Fite BioPharma Ltd.s R&D portfolio and
develop key strategic initiatives to reinforce pipeline in those areas
Exploit in­licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Can­Fite BioPharma Ltd. and exploit
collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter­
strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Can­Fite
BioPharma Ltd.
Develop and design in­licensing and out­licensing strategies by identifying prospective partners with the
most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Can­Fite BioPharma Ltd. and identify potential
opportunities in those areas
Avoid Intellectual Property Rights related issues

4. Request To Download Sample Report @ http://www.researchmoz.us/enquiry.php?
type=sample&repid=285962
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We
fulfill all your research needs spanning across industry verticals with our huge collection of market research reports.
We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research
Coordinators have in­depth knowledge of reports as well as publishers and will assist you in making an informed
decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
Tel: +1­518­618­1030
Toll Free: 866­997­4948
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/